217 related articles for article (PubMed ID: 32513891)
21. [Implementing next-generation sequencing for precision hematology/oncology].
Maeda T
Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
[TBL] [Abstract][Full Text] [Related]
22. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
23. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
Subbiah V; Kurzrock R
Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
[TBL] [Abstract][Full Text] [Related]
24. Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients.
Hernandez-Martinez JM; Sánchez-Reyes R; De la Garza-Salazar JG; Arrieta O
Adv Exp Med Biol; 2019; 1168():79-90. PubMed ID: 31713165
[TBL] [Abstract][Full Text] [Related]
25. The coming decade in precision oncology: six riddles.
Wahida A; Buschhorn L; Fröhling S; Jost PJ; Schneeweiss A; Lichter P; Kurzrock R
Nat Rev Cancer; 2023 Jan; 23(1):43-54. PubMed ID: 36434139
[TBL] [Abstract][Full Text] [Related]
26. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
[TBL] [Abstract][Full Text] [Related]
27. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
28. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
29. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
[TBL] [Abstract][Full Text] [Related]
30. OncoPubMiner: a platform for mining oncology publications.
Xu Q; Liu Y; Hu J; Duan X; Song N; Zhou J; Zhai J; Su J; Liu S; Chen F; Zheng W; Guo Z; Li H; Zhou Q; Niu B
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36058206
[TBL] [Abstract][Full Text] [Related]
31. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
32. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
[TBL] [Abstract][Full Text] [Related]
33. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
34. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
Özdemir V; Arga KY; Aziz RK; Bayram M; Conley SN; Dandara C; Endrenyi L; Fisher E; Garvey CK; Hekim N; Kunej T; Şardaş S; Von Schomberg R; Yassin AS; Yılmaz G; Wang W
OMICS; 2020 Feb; 24(2):62-80. PubMed ID: 32027574
[TBL] [Abstract][Full Text] [Related]
35. Bayesian approach to incorporating different types of biomedical knowledge bases into information retrieval systems for clinical decision support in precision medicine.
Balaneshinkordan S; Kotov A
J Biomed Inform; 2019 Oct; 98():103238. PubMed ID: 31301513
[TBL] [Abstract][Full Text] [Related]
36. Precision oncology: A primer for pediatric surgeons from the APSA cancer committee.
Harris CJ; Waters AM; Tracy ET; Christison-Lagay E; Baertshiger RM; Ehrlich P; Abdessalam S; Aldrink JH; Rhee DS; Dasgupta R; Rodeberg DA; Lautz TB
J Pediatr Surg; 2020 Sep; 55(9):1706-1713. PubMed ID: 31718869
[TBL] [Abstract][Full Text] [Related]
37. Defining the publication source of high-quality evidence in urology: an analysis of EvidenceUpdates.
Narayan VM; Chrouser K; Haynes RB; Parrish R; Dahm P
BJU Int; 2016 Jun; 117(6):861-6. PubMed ID: 26663761
[TBL] [Abstract][Full Text] [Related]
38. PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.
Basu S; Alavi A
PET Clin; 2016 Jul; 11(3):203-7. PubMed ID: 27321025
[TBL] [Abstract][Full Text] [Related]
39. Functional precision oncology using patient-derived assays: bridging genotype and phenotype.
van Renterghem AWJ; van de Haar J; Voest EE
Nat Rev Clin Oncol; 2023 May; 20(5):305-317. PubMed ID: 36914745
[TBL] [Abstract][Full Text] [Related]
40. Qualifying and quantifying the precision medicine rhetoric.
Lee J; Hamideh D; Nebeker C
BMC Genomics; 2019 Nov; 20(1):868. PubMed ID: 31730456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
